Tag: source

MONTRÉAL, 03 juill. 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade commercial, annonce aujourd’hui que la Société dévoilera ses résultats financiers pour le deuxième trimestre de l’exercice financier de 2025, clos le 31 mai 2025, le mercredi 9 juillet 2025.

MONTREAL, July 03, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced the Company will report financial results for its second quarter 2025 ended May 31 on Wednesday, July 9, 2025.

Featuring Sukre™ for GLUT-4 Receptor Support, Gluco6 Highlights Non-Synthetic Compounds and 2025 Trends in Plant-Based Glucose Wellness

Core Adjusted EBITDA exceeds guidance; Company re-affirms FY 2026 outlook as AI-Centric Global Capability Center strategy accelerates

MISSISSAUGA, Ontario, July 03, 2025 (GLOBE NEWSWIRE) -- Bird Construction Inc. (TSX: BDT) announced today that it will release its 2025 second quarter financial results after market close on Wednesday, August 13, 2025. A conference call and live webcast to discuss the results will be held on Thursday, August 14, 2025 at 10:00 a.m. (ET).

BEDFORD, Mass., July 03, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on July 1, 2025, Anika granted non-statutory stock options (“Options”) covering an aggregate of 2,500 shares of common stock at a per share exercise price of $10.53, which equaled the closing price of common stock on the Nasdaq Global Select Market (“Closing Price”) on the grant date, to one newly hired non-executive employee. The grant was made pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, was approved by the compensation committee of the board of directors pursuant to a delegation of authority by the board of directors, and, in accordance with Nasdaq Listing Rule 5635(c)(4), was made as a material inducement to the grantee’s acceptance of employment with Anika as a component of the grantee’s employment compensation.

CALGARY, Alberta, July 03, 2025 (GLOBE NEWSWIRE) -- TransAlta Corporation (“TransAlta”) (TSX:TA)(NYSE:TAC) will release its second quarter 2025 results before markets open on Friday, August 1, 2025. A conference call and webcast to discuss the results will be held for investors, analysts, members of the media and other interested parties the same day beginning at 9:00 a.m. Mountain Time (11:00 a.m. ET).